Influence of cisplatin-induced renal failure on the α1-adrenoceptor subtype causing vasoconstriction in the kidney of the rat

European Journal of Pharmacology

Volumn 569, Issue 1-2, 2007, Pages 110-118

  Khan, Abdul H ^a   Sattar, Munavvar A ^a   Abdullah, Nor A ^b   Johns, Edward J ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

1 Adrenoceptor subtypes; Renal failure; Renal vasculature

Indexed keywords

AMLODIPINE; ANIMALS; CISPLATIN; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY FAILURE; MALE; METHOXAMINE; NOREPINEPHRINE; PHENYLEPHRINE; PIPERAZINES; RATS; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, ALPHA-1; RENAL CIRCULATION; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 34547459679     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.04.063     Document Type: Article

References (32)

1. 1D- and α1A-adrenoceptors in contraction of rat mesenteric artery. Vasc. Pharmacol. 40 (2003) 91-96
2. Armenia A., Munavvar A.S., Abdullah N.A., Helmi A., and Johns E.J. The contribution of adrenoceptor subtypes in the renal vasculature of diabetic spontaneously hypertensive rats. Br. J. Pharmacol. 142 (2004) 719-726
3. Abbas, S.A., 2003. The control of renal hemodynamics by the adrenergic nervous system in a combined state of hypertension, heart failure and diabetes: role of α-adrenoceptor subtypes. Ph D Dissertation. Universiti Sains Malaysia, Penang, Malaysia.
4. Blue D.R., Vimont R.L., and Clarke D.E. Evidence for a noradrenergic innervation to alpha 1A-adrenoceptors in rat kidney. Br. J. Pharmacol. 107 (1992) 414-417
5. Campese V.M., and Krol E. Neurogenic factors in renal hypertension. Curr. Hypertens. Rep. 4 (2002) 256-260
6. DiBona G.F., and Kopp U.C. Neural control of renal function. Physiol. Rev. 77 (1997) 75-197
7. DiBona G.F., and Sawin L.L. Effect of renal nerve stimulation on responsiveness of the rat renal vasculature. Am. J. Physiol. 283 (2002) F1056-F1065
8. Docherty J.R., and O'Rourke M. The α-adrenoceptor-mediated actions of chloroethylclonidine. Gen. Pharmacol. 28 (1997) 197-201
9. Elhawary A.M., Pettinger W.A., and Wolf D.W. Subtype selective alpha1-adrenoceptor alkylation in the rat kidney and its effect on the vascular pressure responses. J. Pharmacol. Exp. Ther. 260 (1992) 709-713
10. Fuji T., Kuratam H., Takaokam M., Muraoka T., Fuji Y., Shokoji T., Nishiyama A., Abe Y., and Matsumura Y. The role of sympathetic nervous system in the pathogenesis of ischemic acute renal failure. Eur. J. Pharmacol. 481 (2003) 241-248
11. 1D-adrenergic receptors. Biochem. J. 353 (2001) 603-610
12. Guimarães S., and Moura D. Vascular adrenoceptors: an update. Pharmacol. Rev. 53 (2001) 319-356
13. Goetz A.S., King H.K., Ward S.D.C., True T.A., Rimele T.J., and Saussy Jr. D.L. BMY 7378 is a selective antagonist of D subtype of α1-adrenoceptor. Eur. J. Pharmacol. 272 (1995) R5-R6
14. +2 in smooth muscle. Nature 329 (1987) 33-335
15. Ibarra M., Pardo J.P., López-Guerrer J.J., and Villalobos-Molina R. Differential response to chloroethylclonidine in blood vessels of normotensive and spontaneously hypertensive rats: role of alpha 1D- and alpha 1A-adrenoceptors in contraction. Br. J. Pharmacol. 129 (2000) 653-660
16. Joles A.J., and Koomans H.A. Cause and consequences of increased sympathetic activity in renal diseases. Hypertension 43 (2004) 699-704
17. 1-adrenoceptor mediating renal nerve induced calcium reabsorption by the kidney. Br. J. Pharmacol. 89 (1986) 91-97
18. Kang D.G., Lee A.S., Mun Y.J., Woo W.H., Kim Y.C., Sohn E., Moon M.K., and Lee H.S. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure. Biol. Pharm. Bull. 27 (2004) 366-370
19. Ligtenberg G., Blankestijn P.J., Oey P.L., Klein I.H., Dijkhorst-Oei L.T., Boomsma F., Wieneke G.H., Van Huffelen A.C., and Koomans H.A. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N. Engl. J. Med. 340 (1999) 1321-1328
20. Marjamäki A., Pihlavisto M., Cockcroft V., Heinonen P., Savola J., and Scheinin M. Chloroethylclonidine binds irreversibly to exposed cysteines in the fifth membrane-spanning domain of the human 2A-adrenergic receptor. Mol. Pharmacol. 53 (1998) 370-376
21. Phillips J.K. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents. Clin. Exp. Pharmacol. Physiol. 32 (2005) 415-418
22. Rump L.C., Amann K., Orth S., and Ritz E. Sympathetic over activity in renal disease; a window to understand progression and cardiovasacular complications of uraemia?. Nephrol. Dial. Transplant. 15 (2000) 1735-1738
23. Salomonsson M., and Arendshorst W.J. Calcium recruitment in renal vasculature: NE effects on blood flow and cytosolic calcium concentration. Am. J. Physiol. 276 (1999) F700-F710
24. 1-adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies. Am. J. Physiol. 278 (2000) F138-F147
25. Sattar M., and Johns E.J. Alpha 1-adrenoceptor subtypes mediating adrenergic vasoconstriction in kidney, one-clip Goldblatt and deoxycorticosterone acetate-salt hypertensive rats. J. Cardiovasc. Pharmacol. 24 (1994) 420-428
26. Stassen F.R., Mass R.G., Schiffers P.M., Janssen G.M., and De Mey J.G. A positive and reversible relationship between adrenergic nerves and alpha-1A adrenoceptors in rat arteries. J. Pharmacol. Exp. Ther. 284 (1998) 399-405
27. ++ signaling mechanism and plays a different physiological role. J. Pharmacol. Exp. Ther. 38 (1990) 725-736
28. ++ influx. J. Pharmacol. Exp. Ther. 36 (1989) 166-176
29. 1A subtypes. Eu. J. Pharmacol. 298 (1996) 257-263
30. Villalobos-Molina R., López-Guerrero J.J., and Ibarra M. Alpha1D- and alpha1A-adrenoceptors mediate contraction rat renal artery. Eur. J. Pharmacol. 322 (1997) 225-227
31. Walsh M.P. Regulation of vascular smooth muscle tone. Can. J. Physiol. Pharm. 72 (1994) 472-476
32. Yatsu T., Aoki M., and Inagaki O. Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats. Eur. J. Pharmacol. 461 (2003) 191-195